Quality Tested Third-Party Verified Highly Purified U.S. Based Expert Support
PhysIQ PeptidesPhysIQ Peptides
Back to Shop
Cagrilintide 5mg research peptide vial

Cagrilintide

Cagrilintide (NN9838)

Cagrilintide is a synthetic, long-acting analog of amylin, a 37-amino-acid peptide hormone co-secreted with insulin by pancreatic beta cells. Native amylin is short-lived and prone to forming insoluble fibrils, which limits its use in research. Cagrilintide was engineered to address both problems: amino-acid substitutions reduce fibrillation, and N-terminal acylation with a fatty diacid promotes albumin binding for an extended half-life.

The design of cagrilintide was described by Kruse and colleagues in the Journal of Medicinal Chemistry in 2021. It is used in the laboratory to study amylin receptor pharmacology, which is unusual because amylin receptors are formed by the calcitonin receptor paired with receptor activity-modifying proteins (RAMPs).

Cagrilintide is an investigational compound and is not approved by the FDA. PhysIQ Peptides supplies it as a lyophilized powder, third-party tested for purity and identity, for in vitro and laboratory research use only.

Choose how to buy

Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.

$50.00per vial · 5mg
Ask a Question
Third-party tested · Purity ≥99% · For laboratory research use only.
Purity
≥99%
Form
Powder (lyophilized)
CAS Number
1415456-99-3
Molecular Weight
4409.0 g/mol
Available sizes
5mg

Mechanism of Action

Cagrilintide acts as a non-selective agonist at amylin receptors (AMY1–3, formed by the calcitonin receptor with RAMP1, 2 or 3) and at the calcitonin receptor itself. These are Gs-coupled receptors that raise intracellular cAMP. In preclinical models, amylin receptor signaling in the hindbrain is studied for its role in gastric emptying and satiety pathways.

Research Areas

  • ●Amylin receptor (AMY1–3) pharmacology
  • ●Calcitonin receptor and RAMP biology
  • ●Peptide fibrillation and stability studies
  • ●Long-acting peptide analog design

Selected References

  • Kruse T, et al. J Med Chem. 2021;64(15):11183-11194.

Related Products

Cartalax research peptide vial

Cartalax

Purity
≥99%
Size
20mg
Form
Powder
$55.00Per Unit
Cerebrolysin research peptide vial

Cerebrolysin

Purity
≥99%
Size
60mg
Form
Powder
$95.00Per Unit
CJC-1295 (+DAC) research peptide vial

CJC-1295 (+DAC)

Purity
≥99%
Size
5mg
Form
Powder
$65.00Per Unit
CJC-1295 No DAC research peptide vial

CJC-1295 No DAC

Purity
≥99%
Size
10mg
Form
Powder
$72.00Per Unit